| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 631 | 2016 |
| Liver disease induced by radioembolization of liver tumors: description and possible risk factors B Sangro, B Gil‐Alzugaray, J Rodriguez, I Sola, A Martinez‐Cuesta, ... Cancer 112 (7), 1538-1546, 2008 | 386 | 2008 |
| Human cerebral activation during steady-state visual-evoked responses MA Pastor, J Artieda, J Arbizu, M Valencia, JC Masdeu Journal of neuroscience 23 (37), 11621-11627, 2003 | 368 | 2003 |
| Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version … I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ... European journal of nuclear medicine and molecular imaging 46, 540-557, 2019 | 355 | 2019 |
| Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ... The Lancet Neurology 19 (11), 951-962, 2020 | 249 | 2020 |
| Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz MA Pastor, J Artieda, J Arbizu, JM Marti-Climent, I Peñuelas, JC Masdeu Journal of Neuroscience 22 (23), 10501-10506, 2002 | 201 | 2002 |
| The basal ganglia and disorders of movement: pathophysiological mechanisms JA Obeso, MC Rodríguez-Oroz, M Rodríguez, J Arbizu, ... Physiology 17 (2), 51-55, 2002 | 185 | 2002 |
| Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis M Iñarrairaegui, KG Thurston, JI Bilbao, D D'Avola, M Rodriguez, J Arbizu, ... Journal of Vascular and Interventional Radiology 21 (8), 1205-1212, 2010 | 155 | 2010 |
| Neuroimaging as a marker of the onset and progression of Alzheimer's disease JC Masdeu, JL Zubieta, J Arbizu Journal of the neurological sciences 236 (1-2), 55-64, 2005 | 154 | 2005 |
| Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process R Gonzalez-Redondo, D García-García, P Clavero, C Gasca-Salas, ... Brain 137 (8), 2356-2367, 2014 | 146 | 2014 |
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 1885-1912, 2020 | 121 | 2020 |
| The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy N Galldiks, I Law, WB Pope, J Arbizu, KJ Langen NeuroImage: Clinical 13, 386-394, 2017 | 117 | 2017 |
| Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease D Garcia-Garcia, P Clavero, C Gasca Salas, I Lamet, J Arbizu, ... European journal of nuclear medicine and molecular imaging 39, 1767-1777, 2012 | 113 | 2012 |
| Early-and late-onset Alzheimer disease: Are they the same entity? P Tellechea, N Pujol, P Esteve-Belloch, B Echeveste, MR García-Eulate, ... Neurología (English Edition) 33 (4), 244-253, 2018 | 111 | 2018 |
| Sustained attention in a counting task: normal performance and functional neuroanatomy F Ortuno, N Ojeda, J Arbizu, P Lopez, JM Martı-Climent, I Peñuelas, ... Neuroimage 17 (1), 411-420, 2002 | 95 | 2002 |
| European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia … F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor Eur J Neurol 25 (10), 1201-1217, 2018 | 94 | 2018 |
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission … F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor, Z Walker, ... European journal of neurology 25 (10), 1201-1217, 2018 | 91 | 2018 |
| Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 1534-1545, 2018 | 86 | 2018 |
| Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study J Blesa, C Juri, M Collantes, I Peñuelas, E Prieto, E Iglesias, ... Neurobiology of disease 38 (3), 456-463, 2010 | 84 | 2010 |
| Successful thalamic deep brain stimulation for orthostatic tremor J Guridi, MC Rodriguez‐Oroz, J Arbizu, M Alegre, E Prieto, I Landecho, ... Movement disorders 23 (13), 1808-1811, 2008 | 84 | 2008 |
Iván PeñuelasNavarra在 unav.es 的电子邮件经过验证
